乙一
liked
Today's Japanese stocks, these are standing out. I'm hesitating whether to enter or not...
$Disco (6146.JP)$ With earnings coming up, are expectations for good earnings high? However, it seems like it has risen too much beforehand...
$Furukawa Electric (5801.JP)$ $Fujikura (5803.JP)$ $SWCC (5805.JP)$ $Sumitomo Electric Industries (5802.JP)$ The major electrical wire company is jumping all over the place. Is it because of the increase in electricity-related construction in America?
$SoftBank Group (9984.JP)$ It's jumping in the American AI investment news.
$Disco (6146.JP)$ With earnings coming up, are expectations for good earnings high? However, it seems like it has risen too much beforehand...
$Furukawa Electric (5801.JP)$ $Fujikura (5803.JP)$ $SWCC (5805.JP)$ $Sumitomo Electric Industries (5802.JP)$ The major electrical wire company is jumping all over the place. Is it because of the increase in electricity-related construction in America?
$SoftBank Group (9984.JP)$ It's jumping in the American AI investment news.
Translated
10
乙一
Set a live reminder
$Palantir (PLTR.US)$ Japan time on Tuesday, February 4, 2025 at 7:00 a.m., Earnings Call for the fourth quarter of 2024 is scheduled to be held.
Palantir continues to advance as a "leader in data analytics" in the AI field. It has provided advanced AI solutions for government agencies and major corporations, achieving rapid growth. Will there be any materials to further boost the stock price in this Earnings Call?
Don't miss the live broadcast!
This Earnings Call is Subtitles will be delivered in translation format.distributed live. If you wish to view, please'Reservation'button to click.
◆Notes
The content of this live event is provided through caption translation services for your convenience. Captions are generated using Microsoft Azure and Amazon Translate. No warranties, explicit or implied, are made regarding the accuracy, reliability, or precision of machine translation from English to Japanese. In the event of any damages caused by the translation content, our company shall not be held liable for such damages...
Palantir continues to advance as a "leader in data analytics" in the AI field. It has provided advanced AI solutions for government agencies and major corporations, achieving rapid growth. Will there be any materials to further boost the stock price in this Earnings Call?
Don't miss the live broadcast!
This Earnings Call is Subtitles will be delivered in translation format.distributed live. If you wish to view, please'Reservation'button to click.
◆Notes
The content of this live event is provided through caption translation services for your convenience. Captions are generated using Microsoft Azure and Amazon Translate. No warranties, explicit or implied, are made regarding the accuracy, reliability, or precision of machine translation from English to Japanese. In the event of any damages caused by the translation content, our company shall not be held liable for such damages...
Translated
Will the demand for AI push up stock prices? Live streaming of the PLTR Earnings Call with Japanese subtitles.
Feb 4 06:00
11
1
乙一
liked
$Tonix Pharmaceuticals (TNXP.US)$
The U.S. Securities and Exchange Commission, also known as the SEC, approved amendments to Nasdaq's listing rules such as 5810c3a on January 17, 2025.
As a result, companies that have conducted a so-called reverse split, also known as a reverse stock split, within the past year will not be able to conduct another stock consolidation for a year.
Therefore, Tonics will not be able to consolidate stocks again until June 10, 2025, since it completed a stock consolidation on June 10, 2024.
Therefore, Tonix will likely have to apply for an extension to maintain its listing on Nasdaq, so they probably have already applied for the extension.
In the future, there will be a report from this company regarding this matter.
The U.S. Securities and Exchange Commission, also known as the SEC, approved amendments to Nasdaq's listing rules such as 5810c3a on January 17, 2025.
As a result, companies that have conducted a so-called reverse split, also known as a reverse stock split, within the past year will not be able to conduct another stock consolidation for a year.
Therefore, Tonics will not be able to consolidate stocks again until June 10, 2025, since it completed a stock consolidation on June 10, 2024.
Therefore, Tonix will likely have to apply for an extension to maintain its listing on Nasdaq, so they probably have already applied for the extension.
In the future, there will be a report from this company regarding this matter.
Translated
21
乙一
commented on
Translated
2
1
乙一
reacted to
$Quantum (QMCO.US)$ There seem to be people in the comments section who often mistake it for a quantum computer stock just because the name is Quantum, but the business here has nothing to do with quantum computers at all.
However, for some reason, this place tends to rise the most vigorously when quantum computer stocks rise, so there is value in buying if quantum is rising.
However, it is important to be cautious as we do not know when this relationship may fall apart.
However, for some reason, this place tends to rise the most vigorously when quantum computer stocks rise, so there is value in buying if quantum is rising.
However, it is important to be cautious as we do not know when this relationship may fall apart.
Translated
6
乙一
liked
$Tonix Pharmaceuticals (TNXP.US)$
Is it okay to hold onto it forever?
Is it okay to hold onto it forever?
Translated
5
乙一
reacted to
$Gorilla Technology (GRRR.US)$
Couldn't see in front of me because of tears, but when I wiped them away...I had a big loss.
Couldn't see in front of me because of tears, but when I wiped them away...I had a big loss.
Translated
10
1
乙一
commented on
$Gorilla Technology (GRRR.US)$
It's quite terrible to have too many warrants. It's a good example of ending if you don't show gratitude for the small ones soon.
By the way, I saw an article about SBI's NISA purchases ranking high in things like quantum-related matters. You don't buy small cap stocks with NISA.
This year is not as easy as last year, and Inago GAN Ltd will exit for sure lol.
It's quite terrible to have too many warrants. It's a good example of ending if you don't show gratitude for the small ones soon.
By the way, I saw an article about SBI's NISA purchases ranking high in things like quantum-related matters. You don't buy small cap stocks with NISA.
This year is not as easy as last year, and Inago GAN Ltd will exit for sure lol.
Translated
14
2
乙一
liked
Now that the profit and loss for the period from January 1 to December 31, 2024 has been finalized, I want to summarize it.
First of all, what is clear is that achieving a return of +186% (+52.78 million yen) with U.S. individual stocks alone was excessive, and although it turned out well in hindsight, I am convinced that it was completely non-reproducible. The amount I had invested in U.S. stocks at the beginning of the period was less than one-tenth of my current total assets, including this year's profit. Simply put, I was making investments beyond the generally accepted risk tolerance level, on a temporary basis.
However, the main reason for this decision was the belief that from the beginning of the year to the summer, the risk-return of NVDA far exceeded that of any other assets. At that time, NVDA was in a state where ① its products were competitive, ② its market was rapidly growing, ③ its stock price was very undervalued, ④ its financial health was significantly stronger than other U.S. companies accessing that market with high interest rates, and ⑤ the U.S. stocks themselves were facing significant devaluation in cash due to high inflation from monetary easing, ⑥ there were no indicators supporting a rate cut by the U.S., and ⑦ discussion of raising interest rates in Japan was not on the table for a certain period. As a result, the more I analyzed the situation, the more I was prompted to sell Japanese yen assets...
First of all, what is clear is that achieving a return of +186% (+52.78 million yen) with U.S. individual stocks alone was excessive, and although it turned out well in hindsight, I am convinced that it was completely non-reproducible. The amount I had invested in U.S. stocks at the beginning of the period was less than one-tenth of my current total assets, including this year's profit. Simply put, I was making investments beyond the generally accepted risk tolerance level, on a temporary basis.
However, the main reason for this decision was the belief that from the beginning of the year to the summer, the risk-return of NVDA far exceeded that of any other assets. At that time, NVDA was in a state where ① its products were competitive, ② its market was rapidly growing, ③ its stock price was very undervalued, ④ its financial health was significantly stronger than other U.S. companies accessing that market with high interest rates, and ⑤ the U.S. stocks themselves were facing significant devaluation in cash due to high inflation from monetary easing, ⑥ there were no indicators supporting a rate cut by the U.S., and ⑦ discussion of raising interest rates in Japan was not on the table for a certain period. As a result, the more I analyzed the situation, the more I was prompted to sell Japanese yen assets...
Translated
79
4
乙一
reacted to
$Tonix Pharmaceuticals (TNXP.US)$
It seems like the stock price is being manipulated to remain at a certain level.
As a possibility,
1. The company planning to acquire this company is negotiating the acquisition by keeping the stock price within a certain price range.
2. The stakeholders such as the CEO are continuously selling at a fixed price range.
There is a pharmaceutical company with conflicting interests with this company, trying to prevent this company from maintaining its listing.
Because they are initiating Short Sell through hedge funds.
There was a similar situation with ticker NWBO in the past, and it led to a lawsuit with hedge funds.
In order for hedge funds to make large-scale Buy attempts, they are deliberately keeping the stock price low.
Well, in any case, we can only watch and wait for the progress.
There's no reason for the stock price not to rise, so I will hold it like an demon.
It seems like the stock price is being manipulated to remain at a certain level.
As a possibility,
1. The company planning to acquire this company is negotiating the acquisition by keeping the stock price within a certain price range.
2. The stakeholders such as the CEO are continuously selling at a fixed price range.
There is a pharmaceutical company with conflicting interests with this company, trying to prevent this company from maintaining its listing.
Because they are initiating Short Sell through hedge funds.
There was a similar situation with ticker NWBO in the past, and it led to a lawsuit with hedge funds.
In order for hedge funds to make large-scale Buy attempts, they are deliberately keeping the stock price low.
Well, in any case, we can only watch and wait for the progress.
There's no reason for the stock price not to rise, so I will hold it like an demon.
Translated
19
3